Amgen Inc (AMGN)
270.90
+2.03
(+0.76%)
USD |
NASDAQ |
Mar 18, 16:00
271.79
+0.89
(+0.33%)
After-Hours: 04:17
Amgen Gross Profit Margin (Quarterly): 62.03% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 62.03% |
September 30, 2023 | 73.84% |
June 30, 2023 | 74.05% |
March 31, 2023 | 71.83% |
December 31, 2022 | 74.46% |
September 30, 2022 | 76.13% |
June 30, 2022 | 77.10% |
March 31, 2022 | 74.98% |
December 31, 2021 | 74.91% |
September 30, 2021 | 76.01% |
June 30, 2021 | 74.92% |
March 31, 2021 | 74.75% |
December 31, 2020 | 75.93% |
September 30, 2020 | 75.70% |
June 30, 2020 | 76.02% |
March 31, 2020 | 75.44% |
December 31, 2019 | 79.78% |
September 30, 2019 | 81.94% |
June 30, 2019 | 82.76% |
March 31, 2019 | 81.01% |
December 31, 2018 | 82.41% |
September 30, 2018 | 82.44% |
June 30, 2018 | 83.10% |
March 31, 2018 | 83.00% |
December 31, 2017 | 81.75% |
Date | Value |
---|---|
September 30, 2017 | 82.85% |
June 30, 2017 | 82.38% |
March 31, 2017 | 81.77% |
December 31, 2016 | 82.11% |
September 30, 2016 | 82.33% |
June 30, 2016 | 81.54% |
March 31, 2016 | 81.58% |
December 31, 2015 | 80.65% |
September 30, 2015 | 81.93% |
June 30, 2015 | 79.72% |
March 31, 2015 | 79.48% |
December 31, 2014 | 77.81% |
September 30, 2014 | 78.77% |
June 30, 2014 | 79.13% |
March 31, 2014 | 75.89% |
December 31, 2013 | 79.47% |
September 30, 2013 | 83.40% |
June 30, 2013 | 83.22% |
March 31, 2013 | 82.44% |
December 31, 2012 | 79.14% |
September 30, 2012 | 82.06% |
June 30, 2012 | 83.20% |
March 31, 2012 | 81.47% |
December 31, 2011 | 76.42% |
September 30, 2011 | 84.66% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.03%
Minimum
Dec 2023
82.76%
Maximum
Jun 2019
75.68%
Average
75.57%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gilead Sciences Inc | 70.62% |
Johnson & Johnson | 68.23% |
Eli Lilly and Co | 80.88% |
Merck & Co Inc | 73.26% |
Vertex Pharmaceuticals Inc | 85.38% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 113.2% |
Return on Assets | 7.78% |
Return on Invested Capital | 10.60% |
Profit Margin (Quarterly) | 9.36% |
Operating Margin (Quarterly) | 15.51% |
Return on Net Operating Assets | 12.68% |